News About: Goverment


New drug price determination process needs fundamental reform.

In a meeting on the subject of "Problems and reform programs for the drug pricing system of Korea" on May 11 sponsored by several civic groups, Mr. Woo Seok-gyun of the Korean Federation of Medical Groups for Health R...

KFDA to set review standards for clinical studies on 6 therapeutic groups.

The KFDA announced recently that the review standards for clinical studies would be gradually released initially for 6 therapeutic groups including the obesity, stomach cancer and depression therapy to cope with ever ...

New dosage technology clears sibutramine patent huddles.

A new dosage technology for sibutramine, the main active substance of a top anti-obesity drug, Reductil, has been developed, attracting keen interests to the pharmaceutical industry. The technology developer, CTC B...

Pharmaceutical industry may collapse under KORUS FTA.

The Korea and U. S. FTA system may accelerate the domestic drug industry substantially to transform stemming from which the original branded drugs supplied by most of foreign multinational drug corporations may predom...

KFDA to investigate bio equivalency tests for 3,907 drugs.

The KFDA instructed all regional KFDA offices to investigate and report the bio equivalency tests for 3,907 drugs as to which companies assigned the tests or the company actually manufactured the drugs. The investi...

Civic group calling for patented drug prices to reduce.

Two civic groups, People's Participatory Coalition and Health and Medical Coalition, announced a joint statement over the MOHW's optimizing plan for the NHI drug prices dated on May 5 that the drug price reduction pol...

Health Minister said "incompetent drug company to weed out"

As to the government's positive list system Minister Rhyu Shi-min urged the pharmaceutical industry to be cooperative amid the industry's harsh resistance against the system. Minister Rhyu said on May 3 "The positi...

7.9% slash of prices after review on 4,517 drugs.

The MOHW has reviewed the total 4,517 drug prices 4 times since 2002 and made reductions by 7.9% on average. According to the status of the upper limited price reduction through the periodical price reviews, the total...

Defective system made indiscreet over production of copy drugs.

It is pointed out that the recent indiscreet production of too many copy drugs should be blamed for several defective administrative systems including 1) the current drug pricing system to allow 80% of the upper limit...

Wyeth Korea to extend Enbrel's NHI coverage term.

Wyeth Korea said that the NHI reimbursement period of Enbrel inj. would be remarkably extended for the treatment of ankylosing spondylitis taking effect from May this year according to the revised NHI payment standard...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.